NEW YORK, Jan. 21, 2016 /PRNewswire/ -- The global market for point of care (POC) pregnancy and fertility testing is estimated to have reached $851 million in 2015, according to Kalorama Information. The health care market researcher says that the self-test segment of the POC pregnancy and fertility test market is by far the largest, exceeding the professional sector of tests used in hospitals, physician offices and clinics. Kalorama's report, POC Pregnancy and Fertility Testing Market, examines both the self-test and professional sectors of this point of care market.
Point of Care (POC) Pregnancy and Fertility Testing Market can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88267&productid=9583610.
"The over-the-counter sector for pregnancy and ovulation includes tests available in pharmacies and other retail establishments," said Bruce Carlson, Publisher of Kalorama Information. "The POC pregnancy and fertility test market is mature and highly competitive."
Innovation in the self-test segment of the market has come with the introduction of digital test devices, which generally retail for approximately $1 above other brand name pregnancy tests. Examples include Alere's Clearblue Digital Pregnancy Test with Conception Indicator, a rapid pregnancy test that indicates an approximate date of conception.
Key benefits and market drivers for the POC testing market are that POC tests provide rapid results and often may be performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). The self-test segment of the POC pregnancy and fertility test market is by far the largest, exceeding the professional sector of tests used in hospitals, physician offices and clinics.
Infertility is a disease or condition of the reproductive system. It is defined by factors that include on the production of a sufficient number of healthy sperm in the male, the delivery of those sperm through open pathways into the female, and the successful uniting of sperm with a normal ovum. According to the World Health Organization (WHO), fertility issues affect one in ten couples, up to 80 million people globally, and this number is rising. The current goal in the marketplace is to create diagnostic tests that will make it possible for healthcare professionals to personalize infertility treatment to a woman's specific needs.
POC Pregnancy and Fertility Testing Market analyses the testing market, including global POC pregnancy and fertility testing market analysis, 2012-2019; POC pregnancy and fertility self-testing market analysis, 2014 and 2019; POC pregnancy and fertility professional testing market analysis, 2014 and 2019; global POC pregnancy and fertility testing market revenues and market share of leading suppliers, 2014; and 2014 pregnancy and fertility CLIA waivers.
Point of Care (POC) Pregnancy and Fertility Testing Market can be purchased at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88267&productid=9583610.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-led-by-self-testing-global-poc-pregnancy-and-fertility-testing-market-reaches-851-million-300205186.html
SOURCE Kalorama Information